Financhill
Back

Corcept Therapeutics Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
78

CORT
Corcept Therapeutics

Last Price:
52.14
Seasonality Move:
3.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Corcept Therapeutics Stock Forecast

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 33.5% based on the past 20 years of stock performance.
  • Corcept Therapeutics has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
  • Is Corcept Therapeutics Stock Undervalued?
    The current Corcept Therapeutics [CORT] share price is $52.14. The Score for CORT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Corcept Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 33.5% based on the past 20 years of stock performance.

Corcept Therapeutics Stock Rating

Buy
78
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics overpriced?

  • Corcept Therapeutics has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%

Corcept Therapeutics Stock Price History

Is CORT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com

52-Week Data

52-Week High:
52.35
52-Week Low:
20.84

Prediction Charts

Market Cap:
5.46B
Price in USD:
52.14
Volume:
1.23M
Beta:
0.86

Technical Analysis

SMA50:
42.79
SMA100:
37.90
SMA200:
31.51
52-Wk Change:
103.51%

Stock Predictions

  • Is Corcept Therapeutics stock public?
    Yes, Corcept Therapeutics is a publicly traded company.
  • What is the Corcept Therapeutics stock quote today?
    The Corcept Therapeutics stock price is 52.14 USD today.
  • How to buy Corcept Therapeutics stock online?
    You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 46.90 47.27 47.42 46.05
Oct-18 47.79 49.75 50.07 47.46
Oct-21 49.92 49.11 50.00 48.61
Oct-22 49.00 48.92 49.54 48.78
Oct-23 48.57 48.06 49.36 47.51
Oct-24 47.97 47.24 49.04 47.02
Oct-25 47.68 47.28 48.40 47.25
Oct-28 47.51 48.34 49.19 47.44
Oct-29 48.04 48.22 48.73 47.62
Oct-30 47.67 46.81 48.65 46.28
Oct-31 45.99 48.94 49.92 42.01
Nov-1 48.61 47.62 48.97 46.38
Nov-4 47.63 50.07 51.32 47.63
Nov-5 50.00 52.14 52.35 49.51

Corcept Therapeutics Earnings

Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corcept Therapeutics Forecast Revenue Growth

Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.

* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.